via Pioneering Minds
A drug molecule “invented” by artificial intelligence (AI) will be used in human trials in a world first for machine learning in medicine.
It was created by British start-up Exscientia and Japanese pharmaceutical firm Sumitomo Dainippon Pharma.
The drug will be used to treat patients who have obsessive-compulsive disorder (OCD).
Typically, drug development takes about five years to get to trial, but the AI drug took just 12 months.
Exscienta chief executive Prof Andrew Hopkins described it as a “key milestone in drug discovery”.
He told the BBC: “We have seen AI for diagnosing patients and for analysing patient data and scans, but this is a direct use of AI in the creation of a new medicine.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
AI designed drug
- Insilico Medicine Ushers in a New Era by Launching 6th Generation Intelligent Robotics Drug Discovery Laboratory
Insilico Medicine (“Insilico”), a clinical stage, end-to-end artificial intelligence (AI)-driven drug discovery company, held the launch ceremony for Life Star – a 6th generation Intelligent Robotics ...
- Insilico Medicine launches a 6th generation Intelligent Robotics Drug Discovery Laboratory
Insilico Medicine, a clinical stage, end-to-end artificial intelligence (AI)-driven drug discovery company, held the launch ceremony for Life Star – a 6th generation Intelligent Robotics Drug ...
- 'You have to now design and manufacture faster,' AI exec says
Since the start of the pandemic, the pharmaceutical industry's reliance on overseas manufacturing has been in the spotlight.
- Standigm cited as 'Top 10 Generative AI-based startup based on VC Investment, 2019-2021' in Gartner® report
Standigm ranked seventh of 10 Generative AI-based startups based on its level of VC funding. Generative AI uses generative adversarial networks (GANs) to generate data. Once trained on labeled data, ...
- Insilico Medicine launches 6th generation Intelligent Robotics Lab to further accelerate its AI-driven drug discovery
Insilico Medicine (“Insilico”), a clinical stage, end-to-end artificial intelligence (AI)-driven drug discovery company, held the launch ceremony for Life Star – a 6th generation Intelligent Robotics ...
Go deeper with Google Headlines on:
AI designed drug
[google_news title=”” keyword=”AI designed drug” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Machine learning in medicine
- Four distinct subtypes of long COVID defined in machine learning study
Using machine learning to track symptom clusters in around 35,000 COVID patients, researchers have identified four distinct types of long COVID. The findings suggest long COVID is a diverse disease ...
- Pioneering machine learning technique on the hypothalamus gives insight into nature of aggression
Have you ever been cut off while driving and found yourself swearing and laying on the horn? Or come home from a long day at work and lashed out at whoever left the dishes unwashed? From petty anger ...
- What Is Federated Learning in Health Care? And How Should Health IT Teams Prepare?
In this contributed article, Ittai Dayan, co-founder and CEO of Rhino Health, believes that while traditional machine learning has huge potential for medical researchers, its major shortcoming is the ...
- Machine Learning News and Research
Using machine learning and clinical data from electronic health records, researchers at the Icahn School of Medicine at Mount Sinai in New York constructed an in silico, or computer-derived ...
- AI and Machine Learning in Medical Devices: It’s Getting Better All the Time
Bernhard Kappe, CEO of Orthagonal, began his Virtual Engineering Week presentation, “Using AI & Machine Learning to Improve Medical Device Design,” quoting Marc Andreessen, founder of Netscape.
Go deeper with Google Headlines on:
Machine learning in medicine
[google_news title=”” keyword=”machine learning in medicine” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
